Article Text
DTB select
No meaningful cardiovascular outcome data for inclisiran
Abstract
Overview of: Ray KK, Raal FJ, Kallend DG, et al. Inclisiran and cardiovascular events: a patient-level analysis of phase III trials. Eur Heart J 2023;44:129–38.
- Health Care Quality, Access, and Evaluation
- Drug-Related Side Effects and Adverse Reactions
Statistics from Altmetric.com
Footnotes
Contributors DTB Team.
Provenance and peer review Commissioned; internally peer reviewed.